多囊卵巢综合征患者对生活方式干预获益的认知度调查

doi:10.3969/j.issn.1006-7795.2023.04.009

摘要/Abstract

摘要： 目的探讨多囊卵巢综合征（polycystic ovarian syndrome, PCOS）患者对生活方式干预获益的认知度及其认知度的影响因素，为提高PCOS患者个体化治疗依从性方面提供临床依据。方法采用自制调查问卷对2022年1月至2022年6月在首都医科大学附属北京妇产医院内分泌科就诊的262例PCOS确诊患者就其对生活方式干预获益知识的知晓情况（包括改善代谢，改善内分泌、改善妊娠状况、改善精神状况及降低远期并发症风险4个维度，总分15分）进行了调查。同时调查了患者的体质量指数（body mass index, BMI）、文化程度、收入水平等人口学特征和对PCOS疾病相关知识的认识及就诊相关问题。采用知识知晓率评价PCOS患者对生活方式干预的认知度，采用多元线性回归分析评估PCOS患者生活方式干预认知度的影响因素。结果回收有效问卷234份，有效回收率89.31%。PCOS患者对生活方式干预获益的认知度平均（6.08±4.25）分，总体知晓率40.53%。4个维度中，改善代谢的知晓率为58.33%，改善内分泌的知晓率为36.2%，改善妊娠状况的知晓率为36.75%，改善精神状况及降低远期并发症风险的知晓率为35.0%。文化程度高、收入水平高、PCOS知识了解程度高、有生活方式干预目标与知晓总分呈正相关（P<0.01），而BMI与知晓总分呈负相关（P=0.022）。结论 PCOS 患者对生活方式干预获益的认知度处于低水平。医护人员需要加强PCOS患者在生活方式干预认知方面的教育，并制定个体化干预治疗目标。

关键词: 多囊卵巢综合征, 生活方式干预, 获益, 认知度

Abstract: Objective To investigate awareness and its influencing factors of the benefits from lifestyle intervention in patients with polycystic ovary syndrome (PCOS) to provide clinical evidence for improving the individualized treatment compliance of PCOS patients. Methods We investigated 262 confirmed PCOS patients in the Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital from January 2022 to June 2022. A self-made questionnaire was used to investigate the awareness of the benefits from lifestyle intervention. It included 4 domains of improving metabolism, improving endocrine, improving pregnancy status, improving mental status and reducing the risk of long-term complications, with 15 score in total. The demographic characteristics such as body mass index (BMI), education level and income level, PCOS disease-related knowledge, and medical treatment related problems were investigated. Knowledge awareness rate was used to evaluate PCOS patients' awareness of lifestyle intervention, and multiple linear regression analysis was used to evaluate the influencing factors of their cognition degree of lifestyle intervention. Results Two hundred and sixty-two PCOS women participated in the study, and 234 valid questionnaires were included after screening, with an effective response rate of 89.31%. The mean total score was 6.08±4.25, and the overall awareness rate was 40.53%. The awareness rate of improving metabolism, improving endocrine, improving pregnancy status, and improving mental status and reducing the risk of long-term complications was 58.33%, 36.2%, 36.75%, and 35.0% respectively in 4 domains. Higher education level, higher income level, having more knowledge of PCOS, and having lifestyle intervention goals were positively correlated with the awareness total score（P<0.01）, while BMI was negatively correlated with the awareness total score（P=0.022）. Conclusions The awareness of the benefits from lifestyle intervention in PCOS patients was at low level. Medical staff need to advance the understanding of lifestyle intervention and formulate individualized intervention treatment goals in PCOS patients.

Key words: polycystic ovary syndrome, lifestyle intervention, benefit, awareness

中图分类号:

R711

田玄玄, 阮祥燕, 金婧, 王娟, 程姣姣. 多囊卵巢综合征患者对生活方式干预获益的认知度调查[J]. 首都医科大学学报, 2023, 44(4): 555-560.

Tian Xuanxuan, Ruan Xiangyan, Jin Jing, Wang Juan, Cheng Jiaojiao. Investigation on awareness of the benefits from lifestyle intervention in patients with polycystic ovary syndrome[J]. Journal of Capital Medical University, 2023, 44(4): 555-560.

参考文献

［1］ Glastras S J, Valvi D, Bansal A. Editorial: developmental programming of metabolic diseases［J］. Front Endocrinol, 2021, 12: 781361.
［2］ Zore T, Joshi N V, Lizneva D, et al. Polycystic ovarian syndrome: long-term health consequences［J］. Semin Reprod Med, 2017, 35(3): 271-281.
［3］ Reyes-Muñoz E, Castellanos-Barroso G, Ramírez-Eugenio B Y, et al. The risk of gestational diabetes mellitus among Mexican women with a history of infertility and polycystic ovary syndrome［J］. Fertil Steril, 2012, 97(6): 1467-1471.
［4］ Rodgers R J, Avery J C, Moore V M, et al. Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus［J］. Endocr Connect, 2019, 8(3): R71-R75.
［5］ Yumiceba V, López-Cortés A, Pérez-Villa, A, et al. Oncology and pharmacogenomics insights in polycystic ovary syndrome: an integrative analysis［J］. Front Endocrinol, 2020, 11:585130.
［6］ Li G, Hu J, Zhang S, et al. Changes in resting-state cerebral activity in women with polycystic ovary syndrome: a functional MR imaging study［J］. Front Endocrinol, 2020, 11:603279.
［7］中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国诊疗指南［J］. 中华妇产科杂志, 2018, 53(1): 2-6.
［8］王笑臣, 杨菁. 重视多囊卵巢综合征患者的生活方式调整［J］. 中华妇产科杂志, 2018, 53(1): 51-54.
［9］ Neven A C H，Laven J，Teede H J，et al. A summary on polycystic ovary syndrome：diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines［J］. Semin Reprod Med, 2018, 36(1): 5-12.
［10］闫雪, 徐兴华, 陈子江. 多囊卵巢综合征对妊娠结局的影响［J］．国际生殖健康／计划生育杂志, 2011, 30(5): 371-374．
［11］何萍. 生活方式干预在多囊卵巢综合征患者健康教育中的应用［J］．中国健康教育, 2016, 32(12): 1128-1130.
［12］卫生部医疗服务标准专业委员会. 多囊卵巢综合征诊断中华人民共和国卫生行业标准［J］. 中华妇产科杂志, 2012, 47(1): 74-75.
［13］周小炫，谢敏，陶静，等. 简易智能精神状态检查量表的研究和应用［J］. 中国康复医学杂志, 2016, 31(6): 694-696.
［14］Ideno Y, Takayama M, Hayashi K, et al. EvaIuation of a Japanese version of the Mini-Mental State Examination in elderly persons［J］. Geriatr Gerontol Int, 2012, 12(2): 310-316.
［15］马亚楠，刘瑞云，姬燕慧，等. 多囊卵巢综合征不孕病人治疗依从性现状及影响因素分析［J］. 护理研究, 2022, 36(13): 2404-2409.
［16］贾鑫，丛革新，刘辉，等. 2017年中国人群超重和肥胖现状调查分析［J］．中国健康教育, 2022, 38(3): 217-227.
［17］Ramírez S, Haddad-Tóvolli R, Radosevic M, et al. Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders［J］. Cell Metab, 2022, 34(2): 269-284, e9.

[1]	巫剑红, 田玉翠, 蒋子雯, 唐世倩, 刘朝晖, 代荫梅. LncRNA FAM95B1调控胰岛素样生长因子2的表达对宫腔粘连发生的影响[J]. 首都医科大学学报, 2023, 44(5): 821-827.
[2]	中国人体健康科技促进会生育力保护与保存专业委员会, 国际妇科内分泌学会中国妇科内分泌学分会, 北京妇产学会内分泌分会, 中华预防医学会生育力保护分会, 中国妇幼健康研究会生殖内分泌专业委员会. 卵巢组织冻存移植防治医源性早发性卵巢功能不全临床应用指南[J]. 首都医科大学学报, 0, (): 695-703.
[3]	王泽铖, 阮祥燕, 李婧, 蒋玲玲, Alfred O.Mueck. 医源性早发性卵巢功能不全对脂代谢的影响[J]. 首都医科大学学报, 2023, 44(4): 535-539.
[4]	马郡, 阮祥燕, 许仲婷, 谷牧青, Alfred O.Mueck. 癸女贞胶囊对卵巢储备功能减退女性妊娠结局的影响[J]. 首都医科大学学报, 2023, 44(4): 540-543.
[5]	金凤羽, 阮祥燕, 秦爽, 许新, 杨瑜, 谷牧青, 李妍秋, 杜娟, 程姣姣, 尹晓丹. 定坤丹在氯米芬促排周期中对薄型子宫内膜的疗效观察[J]. 首都医科大学学报, 2023, 44(4): 550-554.
[6]	赵越, 阮祥燕, 谷牧青, 程姣姣, 王月姣, 金婧. 特纳综合征患者生育及妊娠管理的研究进展[J]. 首都医科大学学报, 2023, 44(4): 561-567.
[7]	刘莉莉, 阮祥燕, 鞠蕊, 杨瑜, 蒋玲玲, 程姣姣, 李妍秋, 谷牧青, 王志坤, 王泽铖, Alfred O.Mueck. 围绝经期及绝经后期女性腰椎骨密度与生殖特点及性激素浓度的相关分析[J]. 首都医科大学学报, 2023, 44(4): 530-534.
[8]	杨瑜, 阮祥燕, 程姣姣, 许新, Alfred O.Mueck. 单侧及双侧卵巢切除对大鼠脂肪组织及子宫质量的影响[J]. 首都医科大学学报, 2023, 44(4): 524-529.
[9]	王志坤, 阮祥燕, 鞠蕊, 杨瑜, 蒋玲玲, 程姣姣, 李妍秋, 谷牧青, 刘莉莉, 王泽铖, Alfred O.Mueck. 围绝经期与绝经后女性雄激素浓度对情绪障碍及性功能障碍的影响[J]. 首都医科大学学报, 2023, 44(4): 517-523.
[10]	程姣姣, 阮祥燕, 杜娟, 谷牧青. 未成熟卵母细胞体外成熟在生育力保护中的应用进展[J]. 首都医科大学学报, 2022, 43(3): 329-335.
[11]	鞠蕊, 阮祥燕, 代荫梅, 白勇涛, 杨瑜, 许新, 程姣姣, 杨幸子, 施琰红, 孙艳华, 李瑞玲. 女性性功能障碍的影响因素研究[J]. 首都医科大学学报, 2022, 43(3): 357-363.
[12]	金凤羽, 阮祥燕, 秦爽, 许新, 杨瑜, 谷牧青, 李妍秋, 杜娟, 程姣姣, 尹晓丹. 定坤丹治疗子宫内膜薄型不孕的临床效果[J]. 首都医科大学学报, 2022, 43(3): 364-368.
[13]	许新, 阮祥燕, 鞠蕊, 杨瑜, 程姣姣, 王志坤, Alfred O. Mueck. 中国女性轻度认知障碍的影响因素及其与绝经症状的关系[J]. 首都医科大学学报, 2022, 43(3): 369-374.
[14]	黄睿, 黄晓武, 吕晓丹, 李斯静, 赵玉婷, 夏恩兰, 李天照. 三维超声对宫腔粘连的诊断价值及基于冠状面成像评分系统的初探[J]. 首都医科大学学报, 2022, 43(3): 380-386.
[15]	周巧云, 黄晓武, 夏恩兰, 赵玉婷, 黄睿. 子宫动脉栓塞后宫腔粘连的生殖结局分析[J]. 首都医科大学学报, 2022, 43(3): 490-494.